期刊文献+

Preparation, Characterization, Biological Activity and 3D Molecular Modeling of Mn(Ⅱ), Co(Ⅱ), Ni(Ⅱ), Cu(Ⅱ), Pd(Ⅱ) and Ru(Ⅲ) Complexes of Some Sulfadrug Schiff Bases 被引量:1

Preparation, Characterization, Biological Activity and 3D Molecular Modeling of Mn(Ⅱ), Co(Ⅱ), Ni(Ⅱ), Cu(Ⅱ), Pd(Ⅱ) and Ru(Ⅲ) Complexes of Some Sulfadrug Schiff Bases
原文传递
导出
摘要 Mn(Ⅱ), Co(Ⅱ), Ni(Ⅱ), Cu(Ⅱ), Pd(Ⅱ) and Ru(Ⅲ) complexes of Schiff bases derived from the condensation of sulfaguanidine with 2,4-dihydroxy benzaldehyde (HL1), 2-hydroxy-l-naphthaldehyde (HL2) and salicylaldehyde (HL3) have been synthesized. The structures of the prepared metal complexes were proposed based on elemental analysis, molar conductance, thermal analysis (TGA, DSC and DTG), magnetic susceptibility measurements and spectroscopic techniques (IR, UV-Vis, and ESR). In all complexes, the ligand bonds to the metal ion through the azomethine nitrogen and a-hydroxy oxygen atoms. The structures of Pd(Ⅱ) complex 8 and Ru(Ⅲ) complex 9 were found to be polynuclear. Two kinds of stereochemical geometries; distorted tetrahedral and distorted square py- ramidal, have been realized for the Cu(Ⅱ) complexes based on the results of UV-Vis, magnetic susceptibility and ESR spectra whereas octahedral geometry was predicted for Co(Ⅱ), Mn(Ⅱ) and Ru(Ⅲ) complexes. Ni(Ⅱ) com- plexes were predicted to be square planar and tetrahedral and Pd(Ⅱ) complexes were found to be square planar. The antimicrobial activity of the ligands and their metal complexes was also investigated against the gram-positive bac- teria Staphylococcus aures and Bacillus subtilis and gram-negative bacteria, Escherichia coli and Pesudomonas aeruginosa, by using the agar dilution method. Chloramphenicol was used as standard compound. The obtained data revealed that the metal complexes are more or less, active than the parent ligand and standard. The X-ray crys- tal structure of HL3 has been also reported. Mn(Ⅱ), Co(Ⅱ), Ni(Ⅱ), Cu(Ⅱ), Pd(Ⅱ) and Ru(Ⅲ) complexes of Schiff bases derived from the condensation of sulfaguanidine with 2,4-dihydroxy benzaldehyde (HL1), 2-hydroxy-l-naphthaldehyde (HL2) and salicylaldehyde (HL3) have been synthesized. The structures of the prepared metal complexes were proposed based on elemental analysis, molar conductance, thermal analysis (TGA, DSC and DTG), magnetic susceptibility measurements and spectroscopic techniques (IR, UV-Vis, and ESR). In all complexes, the ligand bonds to the metal ion through the azomethine nitrogen and a-hydroxy oxygen atoms. The structures of Pd(Ⅱ) complex 8 and Ru(Ⅲ) complex 9 were found to be polynuclear. Two kinds of stereochemical geometries; distorted tetrahedral and distorted square py- ramidal, have been realized for the Cu(Ⅱ) complexes based on the results of UV-Vis, magnetic susceptibility and ESR spectra whereas octahedral geometry was predicted for Co(Ⅱ), Mn(Ⅱ) and Ru(Ⅲ) complexes. Ni(Ⅱ) com- plexes were predicted to be square planar and tetrahedral and Pd(Ⅱ) complexes were found to be square planar. The antimicrobial activity of the ligands and their metal complexes was also investigated against the gram-positive bac- teria Staphylococcus aures and Bacillus subtilis and gram-negative bacteria, Escherichia coli and Pesudomonas aeruginosa, by using the agar dilution method. Chloramphenicol was used as standard compound. The obtained data revealed that the metal complexes are more or less, active than the parent ligand and standard. The X-ray crys- tal structure of HL3 has been also reported.
出处 《Chinese Journal of Chemistry》 SCIE CAS CSCD 2012年第4期881-890,共10页 中国化学(英文版)
关键词 sulfaguanidine transition metal complexes spectral studies biological activity crystal structure mo- lecular modeling sulfaguanidine, transition metal complexes, spectral studies, biological activity, crystal structure, mo- lecular modeling
  • 相关文献

参考文献48

  • 1Nagaraja, P.; Yathirajan, H. S.; Raju, C. R.; Vasantha, R. A.; Na- gendra, P.; Hemantha Kumar, M. S. 1L Farmaco 2003, 58, 1295. 被引量:1
  • 2Topacli, C.; Topacli, A. J. Mol. Struct. 2003, 654, 131. 被引量:1
  • 3Maurya, R. C.;Patei, P. Spect. Lett. 1999, 32, 213. 被引量:1
  • 4Varshney, A. K.; Tandon, J. P. Synth. React. Inorg. Met. Org. Chem. 1987, 17, 651. 被引量:1
  • 5Maurya, R. C.; Mishra, D. D.; Rao, N. S.; Rao, N. N. Synth. React. lnorg. Met. Org. Chem. 1994, 26, 1013. 被引量:1
  • 6Maurya, R. C.; Patel, P. Synth. React. Inorg. Met. Org. Chem. 2003, 33, 801. 被引量:1
  • 7Maurya, R. C.; Pandey, A.; Sutradhar, D. Indian J. Chem. 2004, 43A, 763. 被引量:1
  • 8E1-Baredie, K. Y. Monatshefiefur Chem. 2005, 136, 1139. 被引量:1
  • 9EI-Ghamry, H.; Issa, R.; EI-Baradie, K.; Isagai, K.; Masaoka, S.; Saka, K. Acta Cryst. 2008, E64, 1350. 被引量:1
  • 10Bruker APEX2, Bruker AXS Inc., Madison, Wisconsin, USA, 2006. 被引量:1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部